Fig. 3From: SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancerThe expression, prediction ability, and prognosis relationship of SYNJ2 in LUSC. A The mRNA and protein levels of SYNJ2 expression in LUSC; The p values on the top of boxes are based on the Wilcoxon rank-sum test. B, C The prediction ability of SYNJ2 expression for LUSC. D SYNJ2 expression is related to the prognosis of patients with LUSC based on univariate Cox regression analysis resultsBack to article page